HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Michael J Kovacs Selected Research
Michael J Kovacs Research Topics
Disease
34
Venous Thromboembolism
11/2023 - 02/2003
19
Hemorrhage
01/2023 - 07/2003
14
Pulmonary Embolism
01/2023 - 07/2003
13
Venous Thrombosis (Deep-Vein Thrombosis)
07/2022 - 07/2003
11
Thrombosis (Thrombus)
01/2021 - 05/2003
7
Neoplasms (Cancer)
11/2023 - 07/2003
7
Thrombophilia
01/2023 - 07/2007
6
Multiple Myeloma
02/2015 - 12/2004
5
Thromboembolism
01/2021 - 07/2003
4
Thrombocytopenia (Thrombopenia)
02/2015 - 05/2003
3
Edema (Dropsy)
01/2021 - 08/2008
3
Hyperpigmentation
01/2021 - 08/2008
2
Obesity
01/2021 - 03/2017
2
Body Weight (Weight, Body)
02/2018 - 07/2003
2
Dyspnea (Shortness of Breath)
01/2017 - 02/2013
2
Pregnancy Complications
11/2014 - 07/2007
1
Upper Extremity Deep Vein Thrombosis
11/2023
1
Postthrombotic Syndrome
07/2022
1
Atrial Fibrillation
01/2021
1
Abruptio Placentae (Placental Abruption)
01/2018
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
11/2014
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2014
1
Myeloproliferative Disorders (Myeloproliferative Disorder)
04/2014
1
Hypesthesia (Numbness)
02/2013
1
Constipation
02/2013
1
Second Primary Neoplasms (Neoplasms, Second)
02/2013
1
Neovascular Glaucoma
09/2010
1
Retinal Vein Occlusion
09/2010
1
Hypertension (High Blood Pressure)
07/2007
1
Fatigue
05/2005
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2004
1
Eosinophilia
07/2004
1
Hypereosinophilic Syndrome (Loeffler Endocarditis)
07/2004
1
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2003
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
05/2003
1
Febrile Neutropenia
05/2003
Drug/Important Bio-Agent (IBA)
25
Anticoagulants
IBA
11/2023 - 07/2003
14
Warfarin (Coumadin)
FDA Link
Generic
07/2022 - 05/2003
13
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2021 - 05/2003
9
fibrin fragment D (D-dimer)
IBA
01/2021 - 02/2003
8
Dalteparin (Dalteparin Sodium)
FDA Link
01/2021 - 05/2003
5
Heparin (Liquaemin)
FDA Link
Generic
02/2015 - 05/2003
5
Prednisone (Sone)
FDA Link
Generic
02/2015 - 12/2004
4
Vitamin K
FDA Link
10/2014 - 03/2009
3
edoxaban
IBA
07/2022 - 02/2018
3
Rivaroxaban
IBA
11/2020 - 10/2014
3
Thalidomide (Thalomid)
FDA Link
02/2015 - 12/2004
2
4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acid
IBA
10/2018 - 12/2007
2
Fondaparinux (Arixtra)
FDA Link
02/2015 - 05/2005
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2014 - 11/2006
2
Melphalan (Alkeran)
FDA Link
Generic
02/2013 - 01/2007
2
coumarin
IBA
07/2012 - 07/2003
2
Antibodies
IBA
01/2007 - 05/2003
1
factor V Leiden
IBA
01/2023
1
Factor V (Coagulation Factor V)
IBA
01/2023
1
Prothrombin (Factor II)
IBA
01/2023
1
Rosuvastatin Calcium (Crestor)
FDA Link
01/2022
1
Creatinine
IBA
01/2022
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022
1
Hemoglobins (Hemoglobin)
IBA
01/2022
1
Platelet Aggregation Inhibitors (Antiplatelet Drugs)
IBA
01/2022
1
Combined Oral Contraceptives
IBA
01/2021
1
Contraceptive Agents (Contraceptives)
IBA
01/2021
1
apixaban
IBA
11/2020
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2018
1
Clostridium perfringens epsilon-toxin
IBA
01/2017
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
01/2017
1
argatroban (MPQA)
FDA Link
02/2015
1
danaparoid (Orgaran)
FDA Link
02/2015
1
Thrombin
FDA Link
02/2015
1
Sunitinib (Sutent)
FDA Link
11/2014
1
Acenocoumarol
IBA
10/2014
1
Enoxaparin (Lovenox)
FDA Link
Generic
10/2014
1
Lenalidomide (CC 5013)
FDA Link
02/2013
1
Fluorescein (Funduscein)
FDA Link
Generic
09/2010
1
antineoplaston A10 (A 10)
IBA
07/2009
1
Genetic Markers (Genetic Marker)
IBA
07/2007
1
Inflammation Mediators
IBA
07/2007
1
Immunoglobulin G (IgG)
IBA
01/2007
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2007
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2007
1
Platelet Factor 4
IBA
01/2007
1
vandetanib (ZD6474)
IBA
11/2006
1
Tinzaparin (Innohep)
FDA Link
04/2005
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2004
1
Antiphospholipid Antibodies
IBA
09/2003
1
Coumarins
IBA
07/2003
1
Inosine Triphosphate (ITP)
IBA
05/2003
Therapy/Procedure
26
Therapeutics
01/2023 - 05/2003
2
Duration of Therapy
02/2018 - 03/2017
2
Drug Therapy (Chemotherapy)
02/2015 - 05/2003
1
Catheters
11/2023
1
Aftercare (After-Treatment)
01/2023
1
Knee Replacement Arthroplasty (Total Knee Replacement)
01/2018
1
Stem Cell Transplantation
02/2013
1
Length of Stay
12/2012
1
Critical Care (Surgical Intensive Care)
12/2011
1
Salvage Therapy
08/2008
1
Renal Dialysis (Hemodialysis)
01/2007
1
Secondary Prevention
02/2006